Quantitative Analysis of Therapeutic Antibody Interactions with Fcγ Receptors Using High-Speed Atomic Force Microscopy
Biological and Pharmaceutical Bulletin · 2024
DOI: 10.1248/bpb.b23-00751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Saeko Yanaka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences. Hauptthemen laut MEDLINE: Receptors, IgG, Immunoglobulin G. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
This study employed high-speed atomic force microscopy to quantitatively analyze the interactions between therapeutic antibodies and Fcγ receptors (FcγRs). Antibodies are essential components of the immune system and are integral to biopharmaceuticals. The focus of this study was on immunoglobulin G molecules, which are crucial for antigen binding via the Fab segments and cytotoxic functions through their Fc portions. We conducted real-time, label-free observations of the interactions of rituximab and mogamulizumab with the recombinant FcγRIIIa and FcγRIIa. The dwell times of FcγR binding were measured at the single-molecule level, which revealed an extended interaction duration of mogamulizumab with FcγRIIIa compared with that of rituximab. This is linked to enhanced antibody-dependent cellular cytotoxicity that is attributed to the absence of the core fucosylation of Fc-linked N-glycan. This study also emphasizes the crucial role of the Fab segments in the interaction with FcγRIIa as well as that with FcγRIIIa. This approach provided quantitative insight into therapeutic antibody interactions and exemplified kinetic proofreading, where cellular discrimination relies on ligand residence times. Observing the dwell times of antibodies on the effector molecules has emerged as a robust indicator of therapeutic antibody efficacy. Ultimately, these findings pave the way for the development of refined therapeutic antibodies with tailored interactions with specific FcγRs. This research contributes to the advancement of biopharmaceutical antibody design and optimizing antibody-based treatments for enhanced efficacy and precision.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences.
- Institute for Molecular Science (IMS), National Institutes of Natural Sciences.
- Graduate School of Pharmaceutical Sciences, Nagoya City University.
- Graduate School of Pharmaceutical Sciences, Kyushu University.
- Department of Zoology, Faculty of Science, Kasetsart University.
- Department of Physics and Institute for Glyco-core Research (iGCORE), Nagoya University.
Zitieren
APA
Yanaka, S., Watanabe, H., Yogo, R., Kongsema, M., Kondo, S., Yagi, H., Uchihashi, T., & Kato, K. (2024). Quantitative Analysis of Therapeutic Antibody Interactions with Fcγ Receptors Using High-Speed Atomic Force Microscopy. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00751
Vancouver
Yanaka S, Watanabe H, Yogo R, Kongsema M, Kondo S, Yagi H, et al. Quantitative Analysis of Therapeutic Antibody Interactions with Fcγ Receptors Using High-Speed Atomic Force Microscopy. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00751
BibTeX
@article{Yanaka2024,
author = {Yanaka, Saeko and Watanabe, Hiroki and Yogo, Rina and Kongsema, Mesayamas and Kondo, Sachiko and Yagi, Hirokazu and Uchihashi, Takayuki and Kato, Koichi},
title = {Quantitative Analysis of Therapeutic Antibody Interactions with Fcγ Receptors Using High-Speed Atomic Force Microscopy},
journal = {Biological and Pharmaceutical Bulletin},
year = {2024},
doi = {10.1248/bpb.b23-00751}
}
EUVIMED